Table 7_2

You Are Here: AHRQ Home > Quality & Patient Safety > Measuring Healthcare Quality > National Healthcare Quality & Disparities Reports, 2008 > Data Tables Appendix

Table 7_2_1.1
People age 12 and over who needed treatment for illicit drug use and who received such treatment at a specialty facility in the last 12 months,^a United States, 2003 and 2006
Population group		2006		2003
Population group		Percent	SE	Percent	SE
Total		20.3	1.4	15.0	1.1
Age	12–17	11.2	1.4	8.5	1.0
	18–44	20.0	1.5	16.0	1.3
	45–64	*	*	*	*
	65 and over	*	*	*	*
Gender	Male	19.8	1.9	16.0	1.4
Gender	Female	21.3	2.0	13.4	1.6
Race	White only	19.6	1.5	14.0	1.1
	Black only	25.8	3.9	21.1	4.2
	Asian only	*	*	*	*
	NHOPI only	*	*	*	*
	AI/AN only	*	*	*	*
	Multiple races	*	*	*	*
Ethnicity	Hispanic	24.0	4.7	8.4	1.9
Ethnicity	Non-Hispanic	19.6	1.4	16.1	1.2
Family income,^b age 18 and over	Negative/poor	30.8	3.5	DNA	DNA
	Near poor/low	22.7	3.2	DNA	DNA
	Middle	19.1	3.2	DNA	DNA
	High	16.5	3.5	DNA	DNA
Education, age 18 and over	Less than high school	31.7	3.3	19.4	2.8
	High school graduate	21.9	2.5	17.8	2.1
	At least some college	15.9	2.8	13.1	1.8
Residence location	MSA	19.7	1.6	14.7	1.2
Residence location	Non-MSA	24.1	2.8	17.1	2.8

^a Received any illicit drug treatment at a specialty facility refers to treatment received at a hospital (inpatient), a rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug use, or for medical problems associated with drug use. Respondents were classified as needing treatment for an illicit drug problem if they met at least one of three criteria during the past year: (1), dependent on any illicit drug; (2), abuse of any illicit drug; or (3), received treatment for an illicit drug problem at a specialty facility, i.e., drug and alcohol rehabilitation facilities (inpatient or outpatient), hospitals (inpatient only), and mental health centers. Illicit drugs include marijuana/hashish, cocaine (including crack), inhalants, hallucinogens, heroin, or prescription-type psychotherapeutic medications (nonmedical use).

^b Estimates are based on a revised definition of Poverty Level that incorporates information on family income, size, and composition and is calculated as a percentage of the U.S. Census Bureau's poverty thresholds. Negative/poor refers to household incomes below the Federal poverty line; near poor/low, over the poverty line to just below 200 percent of the poverty line; middle, 200 percent to just below 400 percent of the poverty line; and high, 400 percent of the poverty line and over. These estimates are not comparable with similar estimates published in NSDUH reports prior to 2006. Respondents with unknown poverty information were excluded. See Appendix C of the Results from the 2006 National Survey on Drug Use and Health: National Findings for details on the variable.

DNA - Data have not been analyzed.

* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: AI/AN: American Indian or Alaska Native; NHOPI: Native Hawaiian or Other Pacific Islander; MSA: metropolitan statistical area; SE: standard error.

Source: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, National Survey on Drug Use and Health.